The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia

Even though cytopenia caused by either chemotherapy or radiotherapy is a common complication in cancer patients, chemoradiotherapy remains an essential treatment for the majority of patients. The purpose of this study was to look into the clinical efficacy and cost-effectiveness of recombinant human...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenxian, Gu, Xiaodong, Shao, Lan, Shi, Zhiyong, Lou, Guangyuan, Song, Zhengbo, Zhang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303501/
https://www.ncbi.nlm.nih.gov/pubmed/35909587
http://dx.doi.org/10.1155/2022/2256690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303501/
https://www.ncbi.nlm.nih.gov/pubmed/35909587
http://dx.doi.org/10.1155/2022/2256690

Ejemplares similares